About this Session:
There are four million breast cancer survivors living in the U.S., and about 300,000 new cases are diagnosed each year. One in eight American women will be diagnosed with breast cancer in her lifetime. Even with the availability of genetic testing, 90% of those women had not undergone genetic testing prior to their diagnosis. That gap speaks directly to both awareness and access, concerns that are deeply intertwined. All patients should know that genetic testing exists, and that utilizing it is of importance to themselves and their family. Hear details on the first-ever polygenic breast risk assessment that is available to women with all ancestries and its direct implications on cancer survivorship.